加拿大人需要更好地获得治疗罕见疾病的药物,而不是更多的拒绝
Nigel S B Rawson1, John Adams2
1Affiliate Scholar, Canadian Health Policy Institute, Toronto, ON, Senior Fellow, The Macdonald-Laurier Institute, Ottawa, ON, Senior Fellow, Fraser Institute, Vancouver, BC.
HealthcarePapers
|July 7, 2023
概括
开发和销售用于治疗罕见疾病的昂贵药物正在迅速增加. 目前的高价格是不可持续的,需要大幅降低成本或为这些重要治疗方法提供配给.
科学领域:
- 药物经济学 药物经济学
- 卫生政策 卫生政策
- 罕见疾病研究研究.
背景情况:
- 罕见病药物的研发 (R&D) 和商业化已经大幅扩张.
- 与这些专业治疗相关的不断上升的成本对医疗保健系统构成越来越大的挑战.
- 由于DRD可用性的快速增长,现有的定价模型和访问框架越来越受到压力.
研究的目的:
- 分析DRD市场的"爆炸式增长".
- 评估目前DRD的研发和商业化现状的可持续性.
- 为管理DRD价格和访问提出关键干预措施.
主要方法:
- 文献综述和对DRD市场趋势现有研究的综合.
- 对影响DRD定价和研发的经济因素的分析.
- 讨论关于DRD可访问性的政策影响.
主要成果:
- 该研究发现,DRD行业的"爆炸性增长"显著.
- 目前的研发和商业化轨迹在"现状"下被认为是不可持续的.
- 驱动式驱动器的高成本是一个主要问题,影响了患者的访问.
结论:
- 目前DRD开发和定价的轨迹是不可持续的.
- 对DRD价格的大幅降低至关重要.
- 对DRD的配额使用可能是确保公平分配的必要考虑.
相关概念视频
Prescription, Nonprescription and Orphan Drugs
780
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
780
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Factors Affecting Drug Distribution: Physiological Barriers
257
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
257
Drug Control Governance: Regulatory Bodies and Their Impact
190
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
190
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Pharmacovigilance
903
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
903


